Huangpu enterprise skyrockets China's mass spectrometry development
2023-10-13In recent years, Guangzhou Hexin Instruments, located in Guangzhou's Huangpu district, has achieved significant technological advancements.
Huangpu highlights future of energy storage industry
2023-08-16Guangzhou's Huangpu district co-hosted an industry symposium on energy storage on Aug 9, delving into the prospects of modern energy storage solutions.
Huangpu launches national nanotech innovation contest
2023-07-31Huangpu district is currently calling for participants for the 12th China Innovation & Entrepreneurship Competition - Nanotechnology Industry Innovation Special Competition, with the deadline for entries closing on Aug 30.
Huangpu biopharmaceutical conference boosts industry development
2023-05-29The inaugural Guangzhou International Biopharmaceutical Industry Conference was held from May 25 to 27 in Guangzhou's Huangpu district.
Huangpu ranks 1st in innovation investment in Guangzhou
2023-04-04The Guangzhou Urban Innovation Index Report (2022) was released on March 3.
Huangpu discusses advanced technology application
2022-12-28The 2022 (8th) Industrial Match-making Conference for Advanced Technology Application and Industrialization Development was held in Huangpu district, Guangzhou, on Dec 27.
Huangpu contributes to Chinese aviation tires development
2022-10-12A striking tire-shaped building in Xinlong town, Huangpu district is the site of the Aviation Tire Science Center.
Huangpu selected to be pilot area of Sci-tech China
2022-10-12Huangpu district was recently selected as a municipal-level pilot area of "Science and Technology Innovation China" in Guangzhou.
Hongsing Seed Valley in GDD welcomes tourists
2022-08-02Hongsing Seed Valley, a tourism destination in the Guangzhou Development District (GDD), has an exhibition hall measuring more than 2,600 square meters, a high-tech experience hall, and a scientific museum.
Huangpu makes breakthroughs in anti-cancer drug development
2022-07-13Cadonilimab (PD-1/CTLA-4), the first dual immune checkpoint inhibitor to treat cancer in the world that was developed by Huangpu-based biopharmaceutical company Akeso, was put on the market on July 9.
Links
>
- Investment and Entrepreneurship
- Investment Advantages
- Investment Guide
- Policies
- Key Projects
- Major Industries
- Industrial Parks
- Investment Opportunities
- Technological Innovation
- IPR
- Enterprises
- Talents
Copyright © Guangzhou Development District People's Government.
All rights reserved. Presented by China Daily
粤ICP备16087157号-1
All rights reserved. Presented by China Daily
粤ICP备16087157号-1